Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: November 12, 2002
Last updated: July 17, 2013
Last verified: September 2003
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2008
  Estimated Primary Completion Date: No date given